Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global market for Veterinary Vaccine was estimated to be worth US$ 10810 million in 2023 and is forecast to a readjusted size of US$ 17260 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Vaccine by region & country, by Type, and by Application.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
Market Segmentation
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion
Segment by Type:
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segment by Application
Farm Animal
Companion Animal
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Greece
Ukraine
Moldova
Albania
Serbia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Egypt
South Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Veterinary Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Veterinary Vaccine Product Introduction
1.2 Global Veterinary Vaccine Market Size Forecast
1.2.1 Global Veterinary Vaccine Sales Value (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Volume (2019-2030)
1.2.3 Global Veterinary Vaccine Sales Price (2019-2030)
1.3 Veterinary Vaccine Market Trends & Drivers
1.3.1 Veterinary Vaccine Industry Trends
1.3.2 Veterinary Vaccine Market Drivers & Opportunity
1.3.3 Veterinary Vaccine Market Challenges
1.3.4 Veterinary Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Vaccine Players Revenue Ranking (2023)
2.2 Global Veterinary Vaccine Revenue by Company (2019-2024)
2.3 Global Veterinary Vaccine Players Sales Volume Ranking (2023)
2.4 Global Veterinary Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Veterinary Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Veterinary Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Veterinary Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine
2.9 Veterinary Vaccine Market Competitive Analysis
2.9.1 Veterinary Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Attenuated Vaccines
3.1.2 Inactivated Vaccines
3.1.3 Other
3.2 Global Veterinary Vaccine Sales Value by Type
3.2.1 Global Veterinary Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Veterinary Vaccine Sales Volume by Type
3.3.1 Global Veterinary Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Veterinary Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Veterinary Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Veterinary Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Farm Animal
4.1.2 Companion Animal
4.2 Global Veterinary Vaccine Sales Value by Application
4.2.1 Global Veterinary Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Veterinary Vaccine Sales Volume by Application
4.3.1 Global Veterinary Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Veterinary Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Veterinary Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Vaccine Sales Value by Region
5.1.1 Global Veterinary Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Veterinary Vaccine Sales Volume by Region
5.2.1 Global Veterinary Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Veterinary Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Veterinary Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Veterinary Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Veterinary Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Veterinary Vaccine Sales Value, 2019-2030
5.4.2 North America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Veterinary Vaccine Sales Value, 2019-2030
5.5.2 Europe Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Veterinary Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Veterinary Vaccine Sales Value, 2019-2030
5.7.2 South America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Veterinary Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Vaccine Sales Value
6.2.1 Key Countries/Regions Veterinary Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Veterinary Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Veterinary Vaccine Sales Value, 2019-2030
6.3.2 United States Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Vaccine Sales Value, 2019-2030
6.4.2 Europe Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Vaccine Sales Value, 2019-2030
6.5.2 China Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Vaccine Sales Value, 2019-2030
6.6.2 Japan Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Vaccine Sales Value, 2019-2030
6.7.2 South Korea Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Vaccine Sales Value, 2019-2030
6.9.2 India Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Veterinary Vaccine Product Offerings
7.1.5 Merck Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Veterinary Vaccine Product Offerings
7.2.5 Zoetis Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Introduction and Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Product Offerings
7.3.5 Boehringer Ingelheim Recent Development
7.4 Ceva
7.4.1 Ceva Company Information
7.4.2 Ceva Introduction and Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Veterinary Vaccine Product Offerings
7.4.5 Ceva Recent Development
7.5 CAHIC
7.5.1 CAHIC Company Information
7.5.2 CAHIC Introduction and Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAHIC Veterinary Vaccine Product Offerings
7.5.5 CAHIC Recent Development
7.6 HVRI
7.6.1 HVRI Company Information
7.6.2 HVRI Introduction and Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 HVRI Veterinary Vaccine Product Offerings
7.6.5 HVRI Recent Development
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Information
7.7.2 Ringpu Biology Introduction and Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ringpu Biology Veterinary Vaccine Product Offerings
7.7.5 Ringpu Biology Recent Development
7.8 Yebio
7.8.1 Yebio Company Information
7.8.2 Yebio Introduction and Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Yebio Veterinary Vaccine Product Offerings
7.8.5 Yebio Recent Development
7.9 DHN
7.9.1 DHN Company Information
7.9.2 DHN Introduction and Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 DHN Veterinary Vaccine Product Offerings
7.9.5 DHN Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Introduction and Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WINSUN Veterinary Vaccine Product Offerings
7.10.5 WINSUN Recent Development
7.11 Elanco
7.11.1 Elanco Company Information
7.11.2 Elanco Introduction and Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Elanco Veterinary Vaccine Product Offerings
7.11.5 Elanco Recent Development
7.12 Virbac
7.12.1 Virbac Company Information
7.12.2 Virbac Introduction and Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Virbac Veterinary Vaccine Product Offerings
7.12.5 Virbac Recent Development
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Information
7.13.2 Jinyu Bio-Technology Introduction and Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Offerings
7.13.5 Jinyu Bio-Technology Recent Development
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Company Information
7.14.2 ChengDu Tecbond Introduction and Business Overview
7.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Veterinary Vaccine Product Offerings
7.14.5 ChengDu Tecbond Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Introduction and Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 CAVAC Veterinary Vaccine Product Offerings
7.15.5 CAVAC Recent Development
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Company Information
7.16.2 Kyoto Biken Laboratories Introduction and Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Offerings
7.16.5 Kyoto Biken Laboratories Recent Development
7.17 FATRO
7.17.1 FATRO Company Information
7.17.2 FATRO Introduction and Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 FATRO Veterinary Vaccine Product Offerings
7.17.5 FATRO Recent Development
7.18 Vaksindo
7.18.1 Vaksindo Company Information
7.18.2 Vaksindo Introduction and Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Vaksindo Veterinary Vaccine Product Offerings
7.18.5 Vaksindo Recent Development
7.19 Bio-Labs
7.19.1 Bio-Labs Company Information
7.19.2 Bio-Labs Introduction and Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Bio-Labs Veterinary Vaccine Product Offerings
7.19.5 Bio-Labs Recent Development
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Company Information
7.20.2 Avimex Animal Health Introduction and Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Avimex Animal Health Veterinary Vaccine Product Offerings
7.20.5 Avimex Animal Health Recent Development
7.21 MEVAC
7.21.1 MEVAC Company Information
7.21.2 MEVAC Introduction and Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.21.4 MEVAC Veterinary Vaccine Product Offerings
7.21.5 MEVAC Recent Development
7.22 Biovac
7.22.1 Biovac Company Information
7.22.2 Biovac Introduction and Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Biovac Veterinary Vaccine Product Offerings
7.22.5 Biovac Recent Development
7.23 Atafen
7.23.1 Atafen Company Information
7.23.2 Atafen Introduction and Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Atafen Veterinary Vaccine Product Offerings
7.23.5 Atafen Recent Development
7.24 Dyntec
7.24.1 Dyntec Company Information
7.24.2 Dyntec Introduction and Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Dyntec Veterinary Vaccine Product Offerings
7.24.5 Dyntec Recent Development
7.25 RVSRI
7.25.1 RVSRI Company Information
7.25.2 RVSRI Introduction and Business Overview
7.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.25.4 RVSRI Veterinary Vaccine Product Offerings
7.25.5 RVSRI Recent Development
7.26 Medion
7.26.1 Medion Company Information
7.26.2 Medion Introduction and Business Overview
7.26.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.26.4 Medion Veterinary Vaccine Product Offerings
7.26.5 Medion Recent Development
8 Industry Chain Analysis
8.1 Veterinary Vaccine Industrial Chain
8.2 Veterinary Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion
*If Applicable.